Davis Robert M's Form 4 filing
Merck & Co., Inc. (MRK) · filed Feb 6, 2026
- Accession no.
- 0000310158-26-000030
- Filed
- Feb 6, 2026
- Trade date
- Feb 4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.60M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Robert MCIK 0001363076 | Director, Officer (Chairman, CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Common Stock | SSaleDisposed | −14,972 | $117.38 | −$1,757,413.36 | 476,063.76 | Direct | |
| Feb 4, 2026 | Common Stock | SSaleDisposed | −32,462 | $118.35 | −$3,841,877.7 | 443,601.76 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.